Camlin Fine Sciences acquires Dresen Quimica
Deal expands portfolio into Central America
Camlin Fine Sciences (CFS) has acquired a majority stake in Dresen Quimica S.A.P.I. de C.V., Mexico, to cover Central America and Andean States. CFS acquired a 65% stake in Dresen and its group companies, a leading player in the Mexican food and feed blends business.
CFS is the leading integrated manufacturer of the most preferred traditional antioxidants available. With this acquisition, its portfolio expands to geographies in Central America with products like antioxidant blends (traditional and natural), bactericides, mold inhibitors for animal nutrition, pet food, aqua culture and rendering industries.
“This healthy partnership between CFS and Dresen aims at gaining a global position in Shelf Life Solutions space,” said Ricardo Soto, director, CFS Dresen.
CFS offers an experienced team with industry and market knowledge and along with its vertically integrated manufacturing process, its customers experience the advantage of product stability, steady supply, quality assurance, traceability, transparency and most competitive product pricing over the value chain.
“Our ability to listen, understand, respond and meet the customer’s demand is further enhanced with our Central America operations. Simply put, we have improved our synergies across the American continent which will allow our customers to have more control over the products they want,” said Arturo Davila Cabrera, vice president sales - Mexico, Central America and Andean States. “With our expansion strategy, we aim to provide easy access, enhanced timely delivery and most importantly offer cost-effectiveness to our customers.”